Arch Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2012 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Arch Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2012 to 2023.
  • Arch Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -1.44 USD/shares, a 1.41% decline year-over-year.
  • Arch Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -1.04 USD/shares, a 79.6% increase year-over-year.
  • Arch Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -2.27 USD/shares, a 48.4% increase from 2022.
  • Arch Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -4.4 USD/shares, a 14567% decline from 2021.
  • Arch Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -0.03 USD/shares, a 50% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2 +$2.13 +48.4% Oct 1, 2022 Sep 30, 2023 10-K 2024-02-15
2022 -$4 -$4 -14567% Oct 1, 2021 Sep 30, 2022 10-K 2024-02-15
2021 $0 $0 -50% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-28
2020 $0 Oct 1, 2019 Sep 30, 2020 10-K 2021-12-17
2014 $0 $0 -33.3% Oct 1, 2013 Sep 30, 2014 10-K 2014-12-12
2013 $0 +$0.01 +10% Oct 1, 2012 Sep 30, 2013 10-K 2014-12-12
2012 $0 Oct 1, 2011 Sep 30, 2012 10-K/A 2014-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.